cro.directory
← Compare landing

Fortrea vs Premier Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/fortrea/premier-research

CategoryFortreaPremier Research
Listed sitecrocro
SummaryFortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • Central Laboratory Services
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Clinical Imaging Core Lab
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Central Laboratory Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • GLP Toxicology
  • Safety Pharmacology
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Device & Combination Product Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Peptide
Indications
  • Cardiovascular
  • Metabolic
  • Dermatology
  • Infectious Disease
  • Immunology
  • Nephrology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Respiratory
  • Women's Health
  • Gastroenterology
  • Oncology
  • Immunology
  • Neurology
  • Infectious Disease
  • Rare Disease
  • Dermatology
  • Women's Health
Locations
  • Global operations, United States
  • Headquarters, Durham, NC, United States
  • Dallas, Dallas, TX, United States
  • Daytona Beach, Daytona Beach, FL, United States
  • Madison, Madison, WI, United States
  • Sydney, Sydney, NSW, Australia
  • Beijing, Beijing, China
  • Chengdu, Chengdu, Sichuan, China
  • Dalian, Dalian, Liaoning, China
  • Guangzhou, Guangzhou, China
  • Hangzhou, Hangzhou, Zhejiang, China
  • Hong Kong, Hong Kong, China
  • Nanjing, Nanjing, Jiangsu, China
  • Shanghai, Shanghai, China
  • Seoul, Seoul, South Korea
  • Taipei, Taipei, Taiwan
  • Tokyo, Tokyo, Japan
  • Raanana, Raanana, Israel
  • Istanbul, Istanbul, Turkey
  • Bogotá, Bogotá, Colombia
  • Buenos Aires, Buenos Aires, Argentina
  • Lima, Lima, Peru
  • Mexico City, Mexico City, CDMX, Mexico
  • Santiago, Santiago, Chile
  • São Paulo, São Paulo, SP, Brazil
  • Centurion, Centurion, Gauteng, South Africa
  • Clinical Research Unit, Dallas, TX, United States
  • Clinical Research Unit, Daytona Beach, FL, United States
  • Clinical Research Unit, Madison, WI, United States
  • Office, São Paulo, SP, Brazil
  • Office, Mexico City, CDMX, Mexico
  • Office, Buenos Aires, Argentina
  • Office, Santiago, Chile
  • Office, Lima, Peru
  • Office, Bogotá, Colombia
  • Office, Centurion, Gauteng, South Africa
  • Office, Sydney, NSW, Australia
  • Office, Beijing, China
  • Office, Shanghai, China
  • Office, Guangzhou, China
  • Office, Chengdu, Sichuan, China
  • Office, Dalian, Liaoning, China
  • Office, Hangzhou, Zhejiang, China
  • Office, Nanjing, Jiangsu, China
  • Office, Hong Kong, China
  • Office, Tokyo, Japan
  • Office, Seoul, South Korea
  • Office, Taipei, Taiwan
  • Office, Raanana, Israel
  • Office, Istanbul, Turkey
  • Office, Herzliya, Israel
  • Herzliya, Raanana, Israel
  • Herzliya, Herzliya, Israel
  • Office, Hong Kong, Hong Kong
  • Headquarters, Morrisville, NC, United States
  • Southbank, Southbank, VIC, Australia
  • Sofia, Sofia, Bulgaria
  • Toronto, Mississauga, ON, Canada
  • Prague, Praha, Czech Republic
  • Paris, Paris, France
  • Darmstadt, Darmstadt, Germany
  • Budapest, Budapest, Hungary
  • Bengaluru, Bengaluru, India
  • Auckland, Auckland, New Zealand
  • Warsaw, Warszawa, Poland
  • Bucharest, Bucharest, Romania
  • Bratislava, Bratislava, Slovakia
  • Seoul, Seoul, South Korea
  • Madrid, Madrid, Spain
  • Taipei, Taipei, Taiwan
  • Kyiv, Kyiv, Ukraine
  • Wokingham, Wokingham, Berkshire, United Kingdom
Certifications
  • cGMP · Identifier: In-clinic cGMP Pharmacies
  • FDA · Identifier: cGMP
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.